EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access

A novel frameshift variant of GATA3 (p.Ala17ProfsTer178) responsible for HDR syndrome in a Japanese family

Yutaka Hasegawa, Toshie Segawa, Ai Chida, Eriko Yoshida, Hirofumi Kinno, Hiraku Chiba, Tomoyasu Oda, Yoshihiko Takahashi, Koji Nata, Yasushi Ishigaki

Endocrine Journal · 2024

DOI: 10.1507/endocrj.ej24-0147 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Endocrine Journal, 2024. Verfasst von Yutaka Hasegawa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Iwate Medical University, Iwate 028-3695, Japan. Hauptthemen laut MEDLINE: Frameshift Mutation, GATA3 Transcription Factor, Hearing Loss, Sensorineural, Hypoparathyroidism. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HDR syndrome is an autosomal dominant disorder characterized by hypoparathyroidism (H), deafness (D), and renal dysplasia (R) caused by genetic variants of the GATA3 gene. We present the case of a 38-year-old Japanese man with HDR syndrome who exhibited hypoparathyroidism, sensorineural deafness, renal dysfunction, severe symptomatic hypocalcemia with Chvostek's and Trousseau's signs, and QT prolongation on electrocardiography. He had a family history of deafness and hypocalcemia. Genetic testing revealed a novel GATA3 gene variant at exon 2 (c.48delC), which induces a frameshift resulting in termination at codon 178, causing HDR syndrome. We summarized 45 Japanese cases of HDR syndrome with regard to the mode of onset (familial or sporadic) and the age at diagnosis. In addition, we summarized all previous cases of HDR syndrome with GATA3 gene variants. Mapping of previously reported genetic variants in HDR syndrome revealed that most missense variants were observed at exons 4 and 5 regions in the GATA3 gene. These two regions contain zinc finger domains, demonstrating their functional importance in GATA3 transcription. This review of literature provides a useful reference for diagnosing HDR syndrome and predicting the related future manifestations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Frameshift MutationGATA3 Transcription FactorHearing Loss, SensorineuralHypoparathyroidismAdultHumansMaleEast Asian PeopleJapanNephrosisPedigree

Stichwörter der Autor:innen

GATA3Hypoparathyroidismdeafness and renal dysplasia (HDR) syndrome

Substanzen

GATA3 protein, humanGATA3 Transcription Factor

Autor:innen und Institutionen

  • Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Iwate Medical University, Iwate 028-3695, Japan.
  • Division of Medical Biochemistry, School of Pharmacy, Iwate Medical University, Iwate 028-3694, Japan.

Zitieren

APA

Hasegawa, Y., Segawa, T., Chida, A., Yoshida, E., Kinno, H., Chiba, H., Oda, T., Takahashi, Y., Nata, K., & Ishigaki, Y. (2024). A novel frameshift variant of GATA3 (p.Ala17ProfsTer178) responsible for HDR syndrome in a Japanese family. Endocrine Journal. https://doi.org/10.1507/endocrj.ej24-0147

Vancouver

Hasegawa Y, Segawa T, Chida A, Yoshida E, Kinno H, Chiba H, et al. A novel frameshift variant of GATA3 (p.Ala17ProfsTer178) responsible for HDR syndrome in a Japanese family. Endocrine Journal. 2024. doi:10.1507/endocrj.ej24-0147

BibTeX
@article{Hasegawa2024,
  author = {Hasegawa, Yutaka and Segawa, Toshie and Chida, Ai and Yoshida, Eriko and Kinno, Hirofumi and Chiba, Hiraku and Oda, Tomoyasu and Takahashi, Yoshihiko and Nata, Koji and Ishigaki, Yasushi},
  title = {A novel frameshift variant of GATA3 (p.Ala17ProfsTer178) responsible for HDR syndrome in a Japanese family},
  journal = {Endocrine Journal},
  year = {2024},
  doi = {10.1507/endocrj.ej24-0147}
}
Kostenlos starten →